These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 21440735

  • 1. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O.
    Transplant Proc; 2011 Mar; 43(2):466-8. PubMed ID: 21440735
    [Abstract] [Full Text] [Related]

  • 2. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 3. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
    Bajjoka I, Hsaiky L, Brown K, Abouljoud M.
    Liver Transpl; 2008 Jan 15; 14(1):66-72. PubMed ID: 18161842
    [Abstract] [Full Text] [Related]

  • 4. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Jan 15; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

  • 5. Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.
    Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.
    Transplantation; 2008 May 27; 85(10):1391-9. PubMed ID: 18497677
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA, Tischer SM, Lee E, Lee S, Sindelar J, Park JM.
    Pharmacotherapy; 2015 Aug 27; 35(8):748-54. PubMed ID: 26234282
    [Abstract] [Full Text] [Related]

  • 7. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar 27; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.
    Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.
    Transplantation; 2012 Sep 15; 94(5):506-12. PubMed ID: 22895613
    [Abstract] [Full Text] [Related]

  • 9. Modern approaches to combining sirolimus with calcineurin inhibitors.
    Stevens RB.
    Transplant Proc; 2008 Dec 15; 40(10 Suppl):S21-4. PubMed ID: 19100901
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
    Mangus RS, Fridell JA, Vianna RM, Kwo PY, Chen J, Tector AJ.
    Liver Transpl; 2012 Jul 15; 18(7):786-95. PubMed ID: 22237953
    [Abstract] [Full Text] [Related]

  • 11. Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.
    Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.
    Exp Clin Transplant; 2013 Jun 15; 11(3):222-8. PubMed ID: 23432665
    [Abstract] [Full Text] [Related]

  • 12. Risk factors and consequences of delayed graft function in deceased donor renal transplant patients receiving antithymocyte globulin induction.
    Patel SJ, Duhart BT, Krauss AG, Moore LW, Egidi MF, Amiri HS, Gaber LW, Gaber AO.
    Transplantation; 2008 Jul 27; 86(2):313-20. PubMed ID: 18645496
    [Abstract] [Full Text] [Related]

  • 13. Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study.
    Pankewycz O, Leca N, Kohli R, Weber-Shrikant E, Said M, Alnimri M, Feng L, Patel S, Laftavi MR.
    Transplant Proc; 2011 Mar 27; 43(2):519-23. PubMed ID: 21440749
    [Abstract] [Full Text] [Related]

  • 14. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.
    Transplantation; 2009 Jan 27; 87(2):227-32. PubMed ID: 19155977
    [Abstract] [Full Text] [Related]

  • 15. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A, Nart A, Taşli FA, Postaci H, Aykas A, Doğan M, Sahin T.
    Nephrology (Carlton); 2008 Feb 27; 13(1):80-6. PubMed ID: 18199109
    [Abstract] [Full Text] [Related]

  • 16. Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.
    Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE.
    Transplantation; 2012 Aug 27; 94(4):325-30. PubMed ID: 22814328
    [Abstract] [Full Text] [Related]

  • 17. Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy.
    Zachariah M, Nader ND, Brar J, Singh N, Venuto R, Patel S, Said M, Laftavi MR, Pankewycz O.
    Transplant Proc; 2014 Aug 27; 46(1):94-100. PubMed ID: 24507032
    [Abstract] [Full Text] [Related]

  • 18. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation.
    Kamel MH, Mohan P, Little DM, Awan A, Hickey DP.
    J Urol; 2005 Aug 27; 174(2):703-7. PubMed ID: 16006954
    [Abstract] [Full Text] [Related]

  • 19. Depleting antibody induction in simultaneous pancreas-kidney transplantation: a prospective single-center comparison of alemtuzumab versus rabbit anti-thymocyte globulin.
    Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Doares W, Kaczmorski S, Farney AC.
    Expert Opin Biol Ther; 2014 Dec 27; 14(12):1723-30. PubMed ID: 25156622
    [Abstract] [Full Text] [Related]

  • 20. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
    Koch A, Daniel V, Dengler TJ, Schnabel PA, Hagl S, Sack FU.
    J Heart Lung Transplant; 2005 Jun 27; 24(6):708-13. PubMed ID: 15949731
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.